Thomas Doerner

448 total citations
19 papers, 300 citations indexed

About

Thomas Doerner is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Thomas Doerner has authored 19 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Rheumatology and 4 papers in Epidemiology. Recurrent topics in Thomas Doerner's work include Salivary Gland Disorders and Functions (4 papers), Urticaria and Related Conditions (3 papers) and Herpesvirus Infections and Treatments (3 papers). Thomas Doerner is often cited by papers focused on Salivary Gland Disorders and Functions (4 papers), Urticaria and Related Conditions (3 papers) and Herpesvirus Infections and Treatments (3 papers). Thomas Doerner collaborates with scholars based in Germany, Israel and United Kingdom. Thomas Doerner's co-authors include J. Shoham, Talia Hahn, Hanoch Levavi, David Wallach, Josef S Smolen, V. Cohen, Eitan Lunenfeld, I Sarov, M Revel and Marek Glezerman and has published in prestigious journals such as The Lancet, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Thomas Doerner

19 papers receiving 283 citations

Peers

Thomas Doerner
Rosa García-Portales Spain
S Katz United States
Joris Schonkeren Netherlands
Shunji Kaise Japan
John Cafardi United States
Shunichiro Takezaki Japan
Ann‐Marie Lobo United States
Caterina Bodio Italy
Nicole Karras United States
J Granados Mexico
Rosa García-Portales Spain
Thomas Doerner
Citations per year, relative to Thomas Doerner Thomas Doerner (= 1×) peers Rosa García-Portales

Countries citing papers authored by Thomas Doerner

Since Specialization
Citations

This map shows the geographic impact of Thomas Doerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Doerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Doerner more than expected).

Fields of papers citing papers by Thomas Doerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Doerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Doerner. The network helps show where Thomas Doerner may publish in the future.

Co-authorship network of co-authors of Thomas Doerner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Doerner. A scholar is included among the top collaborators of Thomas Doerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Doerner. Thomas Doerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Klotsche, Jens, Thomas Rose, Tilmann Kallinich, et al.. (2021). Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. Lara D. Veeken. 61(8). 3396–3400. 10 indexed citations
2.
3.
Kerschbaumer, Andreas, Josef S Smolen, Peter Nash, et al.. (2020). Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD Open. 6(3). e001374–e001374. 44 indexed citations
4.
Bowman, Simon, Robert I. Fox, Thomas Doerner, et al.. (2019). Ianalumab (VAY736), a Dual Mode of Action Biologic Combining BAFF Receptor Inhibition with B Cell Depletion, for Treatment of Primary Sjogren's Syndrome: Results of an International Randomized, Placebo Controlled Dose Range Finding Study in 190 Patients. 71. 7 indexed citations
5.
Moos, Verena, Frank Heller, Thomas F. Meyer, et al.. (2016). Mucosal Inducible NO Synthase–Producing IgA+ Plasma Cells in Helicobacter pylori–Infected Patients. The Journal of Immunology. 197(5). 1801–1808. 10 indexed citations
6.
Séror, Raphaèle, Gabriel Baron, Claudio Vitali, et al.. (2015). FRI0421 Development of Clinessdai Score (Clinical Eular Sjögren's Syndrome Disease Activity Index) Without Biological Domain: A Tool For Biological Studies. Annals of the Rheumatic Diseases. 74. 579–579. 2 indexed citations
7.
Westhoff, G., et al.. (2012). SAT0223 Dental implants are a treatment option in patients with sjögren's syndrome. Annals of the Rheumatic Diseases. 71. 547–547. 1 indexed citations
8.
Morawietz, Lars, Lorena Martinez‐Gamboa, Gert Hausdorf, et al.. (2009). Expression of Proteasomal Immunosubunit ß1i Is Dysregulated in Inflammatory Infiltrates of Minor Salivary Glands in Sjögren’s Syndrome. The Journal of Rheumatology. 36(12). 2694–2703. 12 indexed citations
9.
10.
Hauser, Anja E., Gwendolin Muehlinghaus, Rudolf A. Manz, et al.. (2003). Long‐Lived Plasma Cells in Immunity and Inflammation. Annals of the New York Academy of Sciences. 987(1). 266–269. 20 indexed citations
11.
Rùzicková, Š, Jiří Vencovský, Olga Kryštůfková, et al.. (2001). Analysis of VH and VL mRNA in single synovial and peripheral B/plasma cells of patients with rheumatoid arthritis. Arthritis Research & Therapy. 3(S2). 1 indexed citations
12.
Glezerman, Marek, Eitan Lunenfeld, Thomas Doerner, et al.. (1989). [Beta-interferon for labial and genital herpes virus infection].. PubMed. 116(2). 88–90. 1 indexed citations
13.
Glezerman, Marek, V. Cohen, J. Shoham, et al.. (1988). PLACEBO-CONTROLLED TRIAL OF TOPICAL INTERFERON IN LABIAL AND GENITAL HERPES. The Lancet. 331(8578). 150–152. 31 indexed citations
14.
Schoenfeld, Alex, et al.. (1987). Treatment of Flat Facial Warts with Interferon‐Beta Cream. The Journal of Dermatologic Surgery and Oncology. 13(3). 299–301. 1 indexed citations
15.
Smetana, Z., et al.. (1987). Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon. Medical Microbiology and Immunology. 176(3). 151–9. 4 indexed citations
16.
Trau, H, M Schewach-Millet, J. Shoham, et al.. (1987). Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.. PubMed. 23(11). 1125–7. 9 indexed citations
17.
Aderka, Dan, Y Levo, Reza Rahmani, et al.. (1985). Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.. PubMed. 21(12). 977–81. 2 indexed citations
18.
Levavi, Hanoch, et al.. (1984). INTRAMUSCULAR HUMAN INTERFERON-β INJECTIONS IN TREATMENT OF CONDYLOMATA ACUMINATA. The Lancet. 323(8385). 1038–1042. 108 indexed citations
19.
Doerner, Thomas, et al.. (1972). Determination of the distribution of 5-bromouracil and 5-iodouracil in the DNA of viable and total phage populations. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 277(1). 25–28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa García-Portales Breakdown of academic impact, for papers by S Katz Breakdown of academic impact, for papers by Joris Schonkeren Breakdown of academic impact, for papers by Shunji Kaise Breakdown of academic impact, for papers by John Cafardi Breakdown of academic impact, for papers by Shunichiro Takezaki Breakdown of academic impact, for papers by Ann‐Marie Lobo Breakdown of academic impact, for papers by Caterina Bodio Breakdown of academic impact, for papers by Nicole Karras Breakdown of academic impact, for papers by J Granados
Rankless by CCL
2026